Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments.
MPH Health Care AG's 3-Year RORE % for the quarter that ended in Dec. 2025 was -267.79%.
The industry rank for MPH Health Care AG's 3-Year RORE % or its related term are showing as below:
FRA:93M1's 3-Year RORE % is ranked worse than 95.51% of 1536
companies
in the Asset Management industry
Industry Median: 12.03
vs FRA:93M1: -267.79
MPH Health Care AG (FRA:93M1) 3-Year RORE % Explanation
Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.
There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 3-year period is chosen.
Be Aware
Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.
MPH Health Care AG 3-Year RORE % Related Terms
MPH Health Care AG 3-Year RORE % Historical Data
* Premium members only.
The historical data trend for MPH Health Care AG's 3-Year RORE % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:93M1 vs BLK, BX, KKR: 3-Year RORE % Comparison
For the Asset Management subindustry, MPH Health Care AG's 3-Year RORE %, along with its competitors' market caps and 3-Year RORE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
MPH Health Care AG 3-Year RORE % vs Asset Management Industry
For the Asset Management industry and Financial Services sector, MPH Health Care AG's 3-Year RORE % distribution charts can be found below:
* The bar in red indicates where MPH Health Care AG's 3-Year RORE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of 3-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Dec. 2025 and 3-year before.
MPH Health Care AG (FRA:93M1) has a 3-Year RORE % of -267.79 as of Dec. 2025. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on MPH Health Care AG and its competitors. According to the industry distribution chart, MPH Health Care AG ranks #1467 out of 1536 companies in the Asset Management industry, placing it in the top 95.5%.
Is MPH Health Care AG's 3-Year RORE % too high?
MPH Health Care AG's current 3-Year RORE % is -267.79. Based on the distribution chart, MPH Health Care AG ranks #1467 out of 1536 companies in the Asset Management industry, which is in the bottom quartile relative to peers. Overall, MPH Health Care AG has a GF Score™ of 63/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does MPH Health Care AG's 3-Year RORE % compare to BLK and BX?
According to the Asset Management industry distribution chart, MPH Health Care AG ranks #1467 out of 1536 companies for 3-Year RORE %. This places MPH Health Care AG in the lower half of its industry. The industry median 3-Year RORE % is 12.03. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year RORE % for an Asset Management company?
The median 3-Year RORE % among Asset Management companies is 12.03, based on 1,536 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year RORE % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year RORE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year RORE % mean?
A high 3-Year RORE % can signal that a stock is expensive relative to its fundamentals. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on MPH Health Care AG and its competitors. For the Asset Management industry, the median 3-Year RORE % is 12.03 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. MPH Health Care AG's current 3-Year RORE % is -267.79. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MPH Health Care AG stock overvalued right now?
Based on GuruFocus' analysis, MPH Health Care AG (FRA:93M1) is currently considered Modestly Undervalued. The stock's GF Value™ is €26.68, compared to a current price of €23.60 — trading 11.5% below its estimated fair value. The current 3-Year RORE % is -267.79. MPH Health Care AG's overall GF Score™ is 63/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year RORE % calculated?
3-Year RORE % is calculated from a company's financial statements. For MPH Health Care AG (FRA:93M1), the current 3-Year RORE % is -267.79 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is MPH Health Care AG (FRA:93M1) Overvalued in 2026?
Based on GuruFocus' analysis, MPH Health Care AG stock appears to be undervalued.
The current stock price of €23.60 is trading 11.5% below its estimated GF Value™ of €26.68.
GuruFocus considers MPH Health Care AG to be Modestly Undervalued.
Key valuation signals for FRA:93M1:
3-Year RORE %: -267.79
GF Value™: €26.68 vs. price of €23.60 (11.5% below fair value)
No single metric tells the full story. See the FRA:93M1 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
MPH Health Care AG is an investment company. Its business activities consist of investing in companies with the goal of capital appreciation. The strategic focus of its activities is on the acquisition and development of companies and company shares, particularly in growth segments of the healthcare market and the pharmaceutical industry.
63GF Score
Get the complete analysis for FRA:93M1
3-Year RORE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:93M1 has been successfully added to your 
